Trial intelligence / Profile preview

Randomised Multicenter Trial Comparing Docetaxel q2w vs q3w in Metastatic Breast Cancer

2005-002467-86Phase 3Completed

Sponsor
Liisa Elomaa
Start
Jul 2005
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of docetaxel in breast cancer, sponsored by Liisa Elomaa. Started Jul 2005; status: completed.

02

Drugs

docetaxel
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2005-002467-86.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-002467-86.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call